hemostasis Flashcards
define hemostasis
cessation of bleeding from a severed blood vessel
define thrombosis
intravascular clot formation
list stages of hemostasis
- vasoconstriction
- platelet plug formation
- blood coagulation
- fibrinolysis
describe adhesion step in plug formation
- adhesion: Von Willebrand factor binds subendothelial collagen which facilitates platelet adhesion through its platelet receptors (GPIb-IX-V) which initiates tethering. collagen’s platelet receptor (GPVI) binds FcRgamma on platelet and this activates alpha2beta1 a2b3 receptors
describe activation/secretion step in platelet plug formation
- activation/secretion: receptor activation activates PIP2 –> IP3 –> Ca+ and PIP2 –> DAG –> PKC, phospholipid –> pLA2 –> arachindonic acid –> PGG2, PGH2 (via COX-1) –> thromboxane A2 (via TXA2 synthase)
these reactions cause an accumulation of thromboxane A, ADP and thrombin which stimulate GCPRs which acts as positive feedback
the granules are released due to increased cytoplasmic calcium
alpha granules of platelets
coagulants/anticoagulants: V, XI, ATIII adhesion proteins: fibrinogen, vWF integral membrane proteins: GPIIb-IIIa growth factors: EGF, TGFbeta angiogenic factors/inhibitors: VEGF, PDFG chemokines and immune mediators
dense granules of platelets
ADP
Ca2+
polyphosphate
serotonin
describe the aggregation step of platelet plug formation
after morphological changes through the inside out signlaing of platelet activation GPIIbIIIIa is able to bind fibrinogen or vWF which other platelets are bind to which allows clumping GPIIbIIIa binding to fibrinogen also causes outside in signaling which further accelerates the aggregation process
what is vWF bound to as it travels in the blood
factor VIII
which antiplatelet drug(s) block COX-1
aspirin and other NSAIDs
which antiplatelet drug(s) block ADP receptor on platelet
clopidogrel
prasurgrel
ticagrelor
cangrelor
which antiplatelet drug(s) blocks thrombin recptor (PAR-1) on platelets
vorapaxar
which antiplatelet drug(s) block fibrinogen and vWF binding to activated GPIIb/IIIa
abciximab
eptifibatide
tirofiban
prostacyclin and platelet plug formation
prostacyclin activates adenylyl cyclase –> cAMP which blocks platelet responses
factors that can activate phospholypase C
vWF, TxA, thrombin
function of phospholupase C in platelet plug formation
PIP2 –> DAG and IP3
IP3 –> Ca+
DAG –> PKC
function of Ca+ in platelet plug formation
initaite platelet responses activate PLA2 (--> aa -->TxA)